Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Rapastinel

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 15,200Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Allergan, following years of turmoil and resistance, heads for split
    Allergan, following years of turmoil and resistance, heads for split

    19 Jun 2019

    // Eric Sagonowsky FIERCE PHARMA

    https://www.fiercepharma.com/pharma/following-years-turmoil-and-resistance-allergan-preparing-to-split-analyst

    Eric Sagonowsky FIERCE PHARMA
    19 Jun 2019
    Share Share
    Allergan chief Saunders takes a painful $2.5B hit on an ugly PhIII flop
    Allergan chief Saunders takes a painful $2.5B hit on an ugly PhIII flop

    08 May 2019

    // John Carroll ENDPTS

    https://endpts.com/allergan-chief-saunders-takes-a-painful-2-5b-hit-on-an-ugly-phiii-flop/

    John Carroll ENDPTS
    08 May 2019
    Share Share
    Rat study suggests Allergan’s failed antidepressant rapastinel- opioid addiction
    Rat study suggests Allergan’s failed antidepressant rapastinel- opioid addiction

    09 Apr 2019

    // Natalie Grover ENDPTS

    https://endpts.com/rat-study-suggests-allergans-failed-antidepressant-rapastinel-may-work-as-opioid-addiction-treatment/

    Natalie Grover ENDPTS
    09 Apr 2019
    Share Share
    Allergan Announces Ph3 Results for Rapastinel as an Adjunctive Treatment (MDD)
    Allergan Announces Ph3 Results for Rapastinel as an Adjunctive Treatment (MDD)

    06 Mar 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/allergan-announces-phase-3-results-for-rapastinel-as-an-adjunctive-treatment-of-major-depressive-disorder-mdd-300808044.html

    PR NEWSWIRE
    06 Mar 2019
    Share Share